Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.
David R CoghillTobias BanaschewskiCaleb BlissBrigitte RobertsonAlessandro ZuddasPublished in: CNS drugs (2019)
NCT01328756.